Changes in Serum Creatinine Levels Can Help Distinguish Hypovolemic From Euvolemic Hyponatremia

Sponsor
Hospital San Carlos, Madrid (Other)
Overall Status
Completed
CT.gov ID
NCT04744987
Collaborator
(none)
122
1
15
8.1

Study Details

Study Description

Brief Summary

Retrospective study that analyzes the changes in serum creatinine as a tool to correctly classify the volemic status volemic status (euvolemia vs hypovolemia) of the patients with hyponatremia.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This study evaluates the usefulness of the changes in serum creatinine in differentiating between euvolemia and hypovolemia in hyponatremic patients. Changes in serum creatinine were retrospectively analyzed . The latter was calculated subtracting the serum creatinine value of eunatremia from that of hyponatremia, and was categorized as an increase when it was "positive", or "decrease/no change" when it was negative or equal to zero. The percentual change in serum creatinine was also calculated.

    Two groups of patients were selected for the current study. First group was conformed by patients with hypovolemic hyponatremia, and second group by patients with euvolemic hyponatremia. Data from eunatremia as well as the hyponatremic episode were collected. Both groups were matched in Receiver operating characteristic curve analyzes where both arithmetical and percentual changes in serum creatinine were assessed and cut-off points were selected for an additional Odd Ratio analysis.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    122 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Retrospective
    Official Title:
    Changes in Serum Creatinine Levels Can Help Distinguish Hypovolemic From Euvolemic Hyponatremia
    Actual Study Start Date :
    Jul 30, 2019
    Actual Primary Completion Date :
    May 30, 2020
    Actual Study Completion Date :
    Oct 30, 2020

    Arms and Interventions

    Arm Intervention/Treatment
    Hypovolemic hyponatremia

    Patients with any cause of hypovolemic hyponatremia were included.

    Euvolemic hyponatremia

    Only patients with euvolemic hyponatremia secondary to Syndrome of inappropriate antidiuresis were included.

    Outcome Measures

    Primary Outcome Measures

    1. Diagnostic Accuracy of the changes in serum creatinine for volemic classification of hyponatremia [4 months]

      Area under the curve from the Receiver operating characteristic curve analysis were calculated for the changes in serum creatinine. Probabilities of each evaluated tool (arithmetic and percentual change in serum creatinine) to correctly classified the volemic status of the hyponatremic patients were calculated.

    Secondary Outcome Measures

    1. Ratio of Correct volemic classification of hyponatremia when Changes in Serum creatinine were used. [4 months]

      Ratio of patients who were correctly classified according to volemic status with different cut-off points obtained from the Receiver operating characteristic curve analyzes. Sensitivity, Specificity, Positive and Negative predictive values were also calculated.

    2. Diagnostic Accuracy of Urine sodium for volemic classification of hyponatremia [4 months]

      Area under the curve from the Receiver operating characteristic curve analysis were calculated for the urine sodium y patients with hyponatremia. Sensitivity, specificity, and Positive and Negative predictive values were calculated.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients with hypovolemic hyponatremia secondary to any cause

    • Patients with euvolemic hyponatremia caused by Syndrome of inappropriate antidiuresis

    • Complete clinical volemia assessment during hyponatremia.

    • Presence of serum creatinine measured in eunatremia as well as in hyponatremic episodes.

    Exclusion Criteria:
    • Pregnants.

    • Patients with a prior history of diabetes, advanced chronic kidney disease (glomerular filtrate rate below 30 ml/min), cirrhosis, or heart failure were excluded.

    • Patients with hypervolemic hyponatremia.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Servicio de Endocrinología y Nutrición. Hospital Clínico San Carlos Madrid Spain 28040

    Sponsors and Collaborators

    • Hospital San Carlos, Madrid

    Investigators

    • Study Director: Isabelle Runkle, MDPhD, Hospital San Carlos, Madrid
    • Principal Investigator: Jorge G Ruiz, MD, Hospital San Carlos, Madrid

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Jorge Gabriel Ruiz Sánchez, Principal investigator, Hospital San Carlos, Madrid
    ClinicalTrials.gov Identifier:
    NCT04744987
    Other Study ID Numbers:
    • creatinine-hyponatremia
    First Posted:
    Feb 9, 2021
    Last Update Posted:
    Aug 3, 2022
    Last Verified:
    Aug 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Jorge Gabriel Ruiz Sánchez, Principal investigator, Hospital San Carlos, Madrid
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 3, 2022